| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.0M | — | +11.1% |
| Cost of Revenue | $7.6M | — | +12.2% |
| Gross Profit | $371K | — | -8.2% |
| R&D Expense | $3.4M | — | -7.3% |
| SG&A Expense | $7.4M | — | +30.8% |
| Operating Income | -$13.9M | — | -18.8% |
| Income Tax | $8K | — | +14.3% |
| Net Income | -$14.3M | — | -26.7% |
| EPS (Basic) | -$0.31 | — | -19.2% |
| EPS (Diluted) | -$0.31 | — | -19.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.8M | -31.0% | -26.9% |
| Accounts Receivable | $6.4M | +103.2% | +40.8% |
| Inventory | $17.4M | -0.8% | -15.8% |
| Current Assets | $49.2M | -19.5% | -28.8% |
| Total Assets | $62.4M | -16.7% | -27.0% |
| Current Liabilities | $19.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.1M | — | -66.1% |
| Capital Expenditures | $394K | — | +23.5% |
| Investing Cash Flow | $8.6M | — | -19.5% |
| Financing Cash Flow | $247K | — | -34.8% |
| Free Cash Flow | -$15.5M | — | -64.7% |
| +27.5% |
| Long-term Debt | $19.1M | +0.8% | — |
| Total Liabilities | $42.0M | +0.8% | +110.4% |
| Stockholders' Equity | $20.4M | -38.6% | -68.9% |